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BACKGROUND: The health data of Central Java, Indonesia showed that diabetes mellitus (DM) was the second most increasing non-communicable 
disease in the province. More than 20 genes have been 
reported to be associated with DM. Calpain-10 (CAPN10) 
polymorphism has been reported to be associated with Type 
2 Diabetes Mellitus (T2DM). However, the association 
between CAPN10 single nucleotide polymorphism (SNP)-
19 and T2DM among Javanese ethnics has never been 
reported. Therefore, this study was conducted to investigate 
the association.
METHODS: After fasting for 8 hours, blood samples 
were drawn from veins of 107 T2DM and 107 non 
diabetic subjects. A half of the drawn blood was collected 
for identification of CAPN10 SNP-19, and another half 
for measuring triglycerides and fasting blood glucose 
(FBG). Identification of CAPN10 SNP-19 was performed 
with polymerase chain reaction (PCR) method, while 
measurement of triglycerides and FBG with colorimetric 
enzymatic method. 
RESULTS: The number of T2DM Javanese subjects 
with 2R/3R and 3R/3R CAPN10 SNP-19 genotypes was 
significantly higher than the number of T2DM Javanese 
subjects with 2R/2R genotype (p=0.002). When each 
number of 2R/3R and 3R/3R T2DM subjects was compared 
with the number of 2R/2R T2DM subjects, the number of 
2R/3R T2DM subjects was significantly higher than the 
number of 2R/2R T2DM subjects (p=0.000). 
CONCLUSION: Javanese subjects with 2R/3R and 3R/3R 
CAPN10 SNP19 genotypes might have susceptibility of 
T2DM.
KEYWORDS: Calpain-10, CAPN10, polymorphism,  type 
2 diabetes mellitus, triglycerides, fasting blood glucose
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Abstract
Introduction
Indonesian lifestyle is continuously changing, which 
causes the shift from infectious to degenerative diseases, 
such as diabetes mellitus (DM). DM is metabolic disorder 
characterized by progressive loss or dysfunction of 
pancreatic β cell.(1) The health data of Central Java, 
Indonesia in 2016 showed that DM was the second most 
increasing non-communicable disease, after hypertension, 
with a rate of 16.42%. In 2006, 972 new DM cases were 
found. Its causes were attributed to age, obesity, fat 
distribution, lack of physical activity, and genetic factors.
(2)  More than 20 genes have been reported to be associated 
with DM. One of the genes is Calpain-10 (CAPN10), 
which is located on chromosome 2q37.3 and encodes 
CAPN10 protein. A previous study showed that CAPN10 
polymorphism was associated with Type 2 DM (T2DM).
(3,4) Calpain-10 was reported to play a role in the insulin 
vesicle exocytosis process of pancreatic β cell and insulin-
stimulated Glucose Transporter 4 (GLUT4) translocation of 
muscle cell and adipocyte.(5) 
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 Insulin resistance, a condition where targeted 
cells fail to respond to the insulin stimulus under normal 
concentration, which can be occurred among patients with 
T2DM. There is also metabolism dysfunctional among these 
patients. Decrease in insulin occurred in the fat tissues, 
leading to a decrease in lipogenesis and an increase in 
lipolysis. Then this will lead to the dyslipidemia, condition 
marked by the increase of triglycerides and Low-Density 
Lipoprotein (LDL), with a decrease in High-Density 
Lipoprotein (HDL).(6) 
 Some studies proved that CAPN10 polymorphism 
increased the risk of insulin resistance and the level of 
free fatty acid (FFA). Obese subjects with CAPN10 single 
nucleotide polymorphism (SNP)-43 and G/G genotype were 
reported to have significant triglyceride level.(7) High level 
of plasma saturated fatty acids and low glucose effectiveness 
were also found in metabolic syndrome subjects with G/G 
genotype.(8) A research on normoglycemic individuals 
proved that subjects with CAPN10 SNP-19 or Del/Ins 19 
(rs3842570) consisting of 2R/3R and 3R/3R genotypes had 
significant lower HDL-C levels compared to the 2R/2R 
genotype.(9) T2DM subjects with homozygous 3R/3R 
genotypes had a significant higher cholesterol level.(10) 
CAPN10 SNP-19 occurred when 2 or 3 repetitions of 32 bp 
in intron-6.
 The involvement of CAPN10 SNP-19 towards the 
triglycerides level of Javanese with T2DM has never been 
reported. Data from Survey of Aspek Kehidupan Rumah 
Tangga Indonesia (Sakerti) or Indonesia Family Life 
Survey (IFLS) in 2007 showed that Javanese and Madurese 
ethnic groups had the highest rates of diabetes in Indonesia, 
by 78.4%.(11) Therefore, this study was conducted to 
investigate the association between CAPN10 SNP-19 and 
T2DM among Javanese ethnics.
Methods
Subject Selection and Sample Collection
A  case  control  study  was  conducted  in  107 T2DM and 107 
non-diabetic selected subjects. All subjects were recruited 
from  the  Primary  Health  Care  Centre  in  Semarang. 
The inclusion criteria were Javanese ethnic, 30-65 years old 
and having no history of cardiovascular disease. Prior to the 
selection, all subjects signed the informed consent. After 
fasting  for  8 hours,  5  mL  of  blood  samples  were  drawn 
from veins of the selected subjects. A half of the drawn blood 
was  collected  for  identification  of  CAPN10  SNP-19, 
while another half for measuring triglycerides and fasting 
blood glucose (FBG). The study protocol was approved 
by Ethics Committee of Faculty of Medicine, Universitas 
Muhammadiyah Semarang (No. 064/EC/FK/2019). 
Identification of CAPN10 SNP-19 
DNA was isolated from the whole blood using GeneJET 
Genomic DNA Purification Kit (Catalog #K0721, 
Thermo Fisher Scientific, Waltham, MA, USA). The 
identification of CAPN10 SNP-19 was conducted by 
peqSTAR 2X Thermocyclers (VWR, Lutterworth, UK) 
with DreamTaq Green PCR Master Mix (2X) (Thermo 
Fisher Scientific). Based on previous report, forward primer 
5'-GTTTGGTTCTCTTCAGCGTGGAG-3' and reverse 
primer 5'-ATGAACCCTGGCAGGGTCTAAG-3' were 
used.(12) PCR was set as follows: the pre-denaturation 
condition at 95oC for 4 min, the 35 cycling condition of 95oC 
for 1 min, 60oC for 30 sec, and 72oC elongation for 1 min, 
and the final extension at 72oC for 10 min. PCR product 
was visualized with 2% of agarose gel. The electrophoresis 
result showed 155 bp of allele 2R (2 repeats of 32 bp/wild 
type) and 187 bp of allele 3R (3 repeats of 32 bp/variant of 
CAPN10 SNP-19). 
Triglycerides and FBG Measurements
Serum of the blood was measured using Triglycerides FS 
(DiaSys Diagnostic Systems, Waterbury, CT, USA) and 
Glucose GOD FS (DiaSys Diagnostic Systems) based on the 
colorimetric enzymatic method with glycerol-3-phosphate-
oxidase and glucose oxidase. Procedure and calculation 
were performed according to the kit inserts. Briefly, serum 
was mixed with each provided reagent, homogenized and 
incubated at room temperature for 10 min. Then the reaction 
was read with spectrophotometer at absorbance of 500 nm 
within 60 min.
Statistical Analysis
Data was calculated using SPSS for Windows version 
15.0 (SPSS Inc., Chicago, IL, USA). Independent T and 
Chi-square tests were applied based on variable scale. The 
p<0.05 was set as significant.
Results
Subject characteristics of T2DM and control subjects are 
shown in Table 1. Age, body mass index (BMI), systolic 
blood pressure (SBP), triglycerides and FBG of T2DM 
subjects were significantly (p<0.05) higher than the control 
subjects (Table 1).
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Table 1. T2DM (n=107) and control (n=107) subject characteristics.
Figure 1. PCR electrophoresis results of wild-
type/variant homozygous/heterozygous CAPN10 
SNP-19 genotypes. A-L lanes: T2DM subjects, 
M-P lanes: control subjects. The 155 bp band: wild-
type, 187 bp band: variant.
Variable Control T2DM   p -value*
Age (year) 30-60 40-69 0.000
Gender (n)
     Male 33 35 -
     Female 74 72 -
BMI (kg/m2) 15.83-35.41 18.90-36.52 0.017
SBP (mm/Hg) 82-158 100-200 0.000
DBP (mm/Hg) 57-114 47-128 0.113
Triglycerides (mg/dL) 4.70-264.28 97.87-310.09 0.000
FBG (mg/dL) 62-123 60-374 0.000
*Analyzed with Independent T-test. 
 PCR electrophoresis results are shown in Figure 1. 
Each C and D lane showed a 155 bp band, suggesting a 
wild-type homozygous (2R/2R) genotype. Each M, N, 
O and P lane showed a 187 bp band, suggesting a variant 
homozygous (3R/3R) genotype. Meanwhile, each A, B, E, 
F, G, H, I, J, K and L lane showed 2 bands, 155 bp and 187 
bp, suggesting a variant heterozygous (2R/3R) genotype. In 
the T2DM group, the highest genotype frequency was the 
2R/3R genotype with a total of 84 subjects (79%).
 The number of T2DM Javanese subjects with 2R/3R 
and 3R/3R CAPN10 SNP-19 genotypes was significantly 
higher than the number of T2DM Javanese subjects with 
2R/2R genotype (p=0.002) (Table 2). When each number 
of 2R/3R and 3R/3R T2DM subjects was compared with 
the number of 2R/2R T2DM subjects, the number of 2R/3R 
T2DM subjects was significantly higher than the number 
of 2R/2R T2DM subjects (p=0.000) (Table 3). Meanwhile, 
the number of 3R/3R T2DM subjects was not significantly 
higher than the number of 2R/2R T2DM subjects.
 T2DM and control subjects characteristics as shown 
in Table 1 were grouped based on the  2R/2R and 2R/3R + 
3R/3R genotypes. However, all parameters including age, 
BMI, SBP, diastolic blood pressure (DBP), triglycerides 
and FBG, did not show any significant difference between 
the groups (Table 4). Although not significant, BMI, 
triglycerides and FBG of 2R/3R + 3R/3R group of T2DM 
subjects were higher than the BMI, triglycerides and FBG of 
2R/2R group of T2DM subjects. In accordance, triglycerides 
and FBG of 2R/3R + 3R/3R group of control subjects were 
also higher than the triglycerides and FBG of 2R/2R group 
of control subjects, although not significant.
Discussion
CAPN10 polymorphism has been reported to have an 
association with the vulnerability of T2DM. The retardation 
of CAPN10 is capable of decreasing insulin secretion in 
pancreatic cells.(13) A study on pancreatic islet of CAPN10 
knockout mice proved that the diminished of CAPN10 altered 
insulin secretion through microtubule associated protein 
1 (MAP1) family.(14) CAPN10 cleavage MAP1 family 
protein into heavy and light chain so enhances its function 
to coordinate microtubule and actin filament. Decreased of 
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Table 2. The differences among the control and T2DM subjects number based on CAPN10 SNP-19 
genotypes.
Table 3. The differences among the control and T2DM subjects number based on CAPN10 SNP-19 
genotypes.
Control T2DM Lower Upper
2R/3R + 3R/3R 81 (75.70%) 98 (91.59%) 0.002 3.495 1.550 7.882
2R/2R 26 (24.30%) 9 (8.41%)
Variable
Subject
p -value* OR
95% CI
*Analyzed with Chi-square test. OR: odd ratio, CI: confidence interval.
Control T2DM Lower Upper
2R/2R 26 (24.30%) 9 (8.41%)
2R/3R 40 (37.38%) 84 (78.50%) 0.000 6.067 2.602 14.142
3R/3R 41 (38.32%) 14 (13.09%) 0.978 0.986 0.374 2.605
Genotype
Subject
p -value* OR
95% CI
*Analyzed with Chi-square test against 2R/2R genotype. OR: odd ratio, CI: confidence interval..
CAPN10 function effects of actin reorganization and insulin 
secretion from b cell. 
 Current results showed that there was a significant 
difference between the number of T2DM Javanese subjects 
with 2R/3R and 3R/3R CAPN10 SNP-19 genotypes than the 
number of T2DM Javanese subjects with 2R/2R genotype. 
This results suggested that CAPN10 SNP-19 genotypes was 
related to the incidence of T2DM. This finding was in line 
with a previous study on the Tunisian Arabs which showed 
that T2DM subjects 2R/3R genotype had significant higher 
risk than the T2DM subjects with 2R/2R genotype.(12) 
Besides in Tunisia, another study in Mexico suggested that 
this polymorphism contributed in the incidence of T2DM as 
well.(15)  
 However, there was no association between the 
CAPN10 SNP-19 and the T2DM on Minangkabau ethnic 
group, even though this ethic is a part of Indonesia.(16) 
Another study in Gaza reported that the most frequent 
genotype of CAPN10 SNP-19 was 3R/3R.(10) Similar to 
Minangkabau, study in Gaza also showed no significant 
association between the CAPN10 SNP-19 and T2DM. 
 T2DM is not only caused by polymorphism factor, but 
also by lifestyle, gender and obesity.(14) Those suffering 
from this disease have dyslipidemia causing chronic 
metabolic disorders characterized by abnormal cytokine 
production, increased acute phase reactants, mediators, and 
activation of inflammatory factors.(17) Insulin resistance of 
T2DM is associated with high triglycerides and low HDL-C 
level although the relationship were still weak.(18) A study 
among population in China (Kazak, Ugyur and Han ethnic) 
also found that there was a relationship between triglycerides 
level and insulin resistance.(19) Insulin resistance seems to 
be closely related with inflammation caused by dietary fatty 
acids. It was hypothesized that there was accumulation of 
diacylglyceride (DAG) that inhibit insulin signaling and 
enhance endoplasmic reticulum stress and oxidative stress.
(20) High fatty acid (especially Arachidonic acid/AA) 
produce 12-HETE which is very toxic to beta pancreas and 
leads to cell destruction.(21)
 Current study also analyzed the association between 
CAPN10 SNP-19 with the level of FBG and triglycerides. 
The results showed FBG and triglycerides of both control 
and T2DM subjects with 2R/3R + 3R/3R genotypes were 
higher than the subjects with 2R/2R genotype, even though 
not significant. Another study showed that both FBG and 
triglycerides level didn't show a significant difference in 
each CAPN10 SNP-19 genotype.(22) However, other study 
noted that subjects with 2R/2R and 2R/3R genotypes had 
a significantly higher concentration of triglycerides than 
subjects with 3R/3R genotype.(23) 
 The variation of CAPN10 has the ability to decrease 
the function of β3 adrenoceptor and adipose cells of obese 
people.(24) The genetic variation of CAPN10 which was 
successfully identified to affect triglycerides level in obese 
people was SNP-43.(6) The obese subjects with SNP-43 
G/G had a significant lower concentration of triglycerides 
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Table 4. The differences of subject characteristics based on CAPN10 SNP-19 genotypes.
*Analyzed with Independent T-test. 
compared to the obese subjects with allele A. Current study 
investigated one type of CAPN10 polymorphism merely. The 
risk of T2DM can be predicted more valid by investigating 
the combination of various CAPN10 polymorphisms, such 
as SNP-44, SNP-43, and SNP-63. Therefore, further study is 
needed to investigate further those SNPs.
Conclusion
Javanese subjects with 2R/3R and 3R/3R CAPN10 SNP19 
genotypes might have susceptibility of T2DM.
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